fingolimod sandoz fingolimod (as hydrochloride) 0.25 mg capsule blister pack
sandoz pty ltd - fingolimod hydrochloride, quantity: 0.28 mg (equivalent: fingolimod, qty 0.25 mg) - capsule, hard - excipient ingredients: mannitol; hyprolose; hydroxypropylbetadex; magnesium stearate; shellac; iron oxide black; propylene glycol; gelatin; strong ammonia solution; titanium dioxide; iron oxide yellow - fingolimod sandoz is indicated for the treatment of adult and paediatric patients of 10 years of age and above with relapsing forms of multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.
gilenya
novartis pharmaceuticals australia pty ltd - fingolimod hydrochloride -
gilenya fingolimod (as hydrochloride) 0.5 mg capsule blister pack
novartis pharmaceuticals australia pty ltd - fingolimod hydrochloride, quantity: 0.56 mg (equivalent: fingolimod, qty 0.5 mg) - capsule, hard - excipient ingredients: mannitol; iron oxide yellow; magnesium stearate; gelatin; titanium dioxide - gilenya is indicated for the treatment of adult and paediatric patients of 10 years of age and above with relapsing forms of multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.
fingolis fingolimod (as hydrochloride) 0.5 mg capsules blister pack
cipla australia pty ltd - fingolimod hydrochloride, quantity: 0.56 mg (equivalent: fingolimod, qty 0.5 mg) - capsule, hard - excipient ingredients: gelatin; fumaric acid; stearic acid; pregelatinised maize starch; titanium dioxide; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - fingolis is indicated for the treatment of relapsing remitting multiple sclerosis and secondary progressive multiple sclerosis with superimposed relapses to delay the progression of physical disability and reduce the frequency of relapse.
tecfidera 120 mg
medison pharma ltd - dimethyl fumarate - gastro resistant hard capsule - dimethyl fumarate 120 mg - dimetyl fumarate - tecfidera is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
tecfidera 120 mg
medison pharma ltd - dimethyl fumarate - gastro resistant hard capsule - dimethyl fumarate 120 mg - dimetyl fumarate - tecfidera is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
tecfidera 120 mg
medison pharma ltd - dimethyl fumarate - gastro resistant hard capsule - dimethyl fumarate 120 mg - dimetyl fumarate - tecfidera is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
tecfidera 120 mg
medison pharma ltd - dimethyl fumarate - gastro resistant hard capsule - dimethyl fumarate 120 mg - dimetyl fumarate - tecfidera is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
tecfidera 120 mg
medison pharma ltd - dimethyl fumarate - gastro resistant hard capsule - dimethyl fumarate 120 mg - dimetyl fumarate - tecfidera is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
tecfidera 240 mg
medison pharma ltd - dimethyl fumarate - gastro resistant hard capsule - dimethyl fumarate 240 mg - dimetyl fumarate - tecfidera is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.